Assessment of response to antimicrobial therapy and time to discharge in patients hospitalized with community-acquired pneumonia

Infectious Diseases in Clinical Practice

Volumn 5, Issue 4 SUPPL., 1996, Pages

  Bartlett, John G ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORIN; PENICILLIN G;

CONFERENCE PAPER; DRUG EFFICACY; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MEDICAL ASSESSMENT; MORTALITY; PNEUMONIA; PROGNOSIS;

EID: 0030481287     PISSN: 10569103     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Fine MJ, Smith MA, Carson CA, et al. Prognosis and outcomes of patients with community-acquired pneumonia: a meta-analysis. JAMA 1996;275:134-41.
2. American Thoracic Society. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. Am Rev Respir Dis 1993;148:1418-26.
3. Campbell GD. Overview of community-acquired pneumonia: prognosis and clinical features. Med Clin North Am 1994;78:1035-48.
4. Fang G-D, Fine M, Orloff J, et al. New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine (Baltimore) 1990;69:307-l6.
5. Gilbert K, Fine MJ. Assessing prognosis and predicting patient outcomes in community-acquired pneumonia. Semin Respir Infect 1994;9:140-52.
6. Granton JT, Grossman RF. Community-acquired pneumonia in the elderly patient: clinical features, epidemiology, and treatment. Clin Chest Med 1993;14:537-53.
7. Leroy O, Santré C, Beuscart C, et al. A five-year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit. Intensive Care Med 1995;21:24-31.
8. Marrie TJ. Community-acquired pneumonia. Clin Infect Dis 1994;18:501-15.